nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
|
Chia, Yvonne May Fen |
|
2018 |
23 |
3 |
p. 461-468 |
artikel |
2 |
Clinical impact of oral antidiabetic medications in heart failure patients
|
Palazzuoli, Alberto |
|
2018 |
23 |
3 |
p. 325-335 |
artikel |
3 |
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
|
Kaplan, Abdullah |
|
2018 |
23 |
3 |
p. 419-437 |
artikel |
4 |
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
|
Krittanawong, Chayakrit |
|
2017 |
23 |
3 |
p. 355-361 |
artikel |
5 |
Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment
|
Terlizzese, Paola |
|
2018 |
23 |
3 |
p. 469-479 |
artikel |
6 |
Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure
|
Anfinogenova, Yana |
|
2017 |
23 |
3 |
p. 481-497 |
artikel |
7 |
Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
|
Oikonomou, Evangelos |
|
2018 |
23 |
3 |
p. 389-408 |
artikel |
8 |
Molecular and clinical roles of incretin-based drugs in patients with heart failure
|
Orabi, Bassant |
|
2018 |
23 |
3 |
p. 363-376 |
artikel |
9 |
Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors
|
Bistola, Vasiliki |
|
2018 |
23 |
3 |
p. 377-388 |
artikel |
10 |
Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus
|
Tanaka, Hidekazu |
|
2018 |
23 |
3 |
p. 439-444 |
artikel |
11 |
SGLT2 inhibition and heart failure—current concepts
|
Custodio, Joaquim Silva |
|
2018 |
23 |
3 |
p. 409-418 |
artikel |
12 |
Still sour about lactic acidosis years later: role of metformin in heart failure
|
Kuan, William |
|
2017 |
23 |
3 |
p. 347-353 |
artikel |
13 |
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
|
Ofstad, Anne Pernille |
|
2018 |
23 |
3 |
p. 303-323 |
artikel |
14 |
The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies
|
Lambadiari, Vaia |
|
2018 |
23 |
3 |
p. 337-346 |
artikel |
15 |
The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
|
Asleh, Rabea |
|
2017 |
23 |
3 |
p. 445-459 |
artikel |